[Effect of a new beta-stimulator (Th 1165a, parahydroxyphenylorciprenaline) on the pulmonary function in chronic obstruction].
D000328:Adult; D000336:Aerosols; D000368:Aged; D001249:Asthma / Q000188:drug therapy; D001991:Bronchitis / Q000188:drug therapy; D002908:Chronic Disease; D005260:Female; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000188:drug therapy*; D008297:Male; D009921:Metaproterenol / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D008875:Middle Aged; D010636:Phenols / Q000627:therapeutic use; D011656:Pulmonary Emphysema / Q000188:drug therapy; D012119:Respiration / Q000187:drug effects
D000336:Aerosols; D010636:Phenols; D009921:Metaproterenol
Die Wirkung eines neuen Beta-Stimulators (Th 1165 a, Parahydroxyphenylorciprenalin) auf die Lungenfunktion von chronisch Obstruktiven